α-Fetoprotein for Hepatocellular Carcinoma Diagnosis: The Demise of a Brilliant Star
Top Cited Papers
- 31 July 2009
- journal article
- editorial
- Published by Elsevier BV in Gastroenterology
- Vol. 137 (1), 26-29
- https://doi.org/10.1053/j.gastro.2009.05.014
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Major achievements in hepatocellular carcinomaThe Lancet, 2009
- The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patientsHepatology, 2006
- Management of hepatocellular carcinomaHepatology, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Screening for Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis: A Cost-Utility AnalysisThe American Journal of Gastroenterology, 2003
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysisGut, 2001
- Combined α fetoprotein testing and ultrasonography as a screening test for primary liver cancerJournal of Medical Screening, 1999
- Rising Incidence of Hepatocellular Carcinoma in the United StatesThe New England Journal of Medicine, 1999
- Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosisAmerican Journal Of Medicine, 1996